Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Genenta Science S.p.A. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 6
- +1 vs. Q2 2025
- Shares held
- 552.0K
- +14.7K (+2.7%) vs. Q2 2025
- Total value
- $1.77M
- −$56.0K (−3.1%) vs. Q2 2025
- New holders
- 2
- 1 more added
- Sold out
- 1
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.33M |
| Q1 2026 | 11 | $695.7K |
| Q4 2025 | 15 | $4.04M |
| Q3 2025 | 6 | $1.77M |
| Q2 2025 | 5 | $1.82M |
| Q1 2025 | 5 | $2.10M |
| Q4 2024 | 4 | $1.42M |
| Q3 2024 | 5 | $1.48M |
| Q2 2024 | 5 | $1.04M |
| Q1 2024 | 5 | $1.92M |
| Q4 2023 | 4 | $3.67M |
| Q3 2023 | 3 | $2.29M |
| Q2 2023 | 4 | $2.73M |
| Q1 2023 | 2 | $273.8K |
| Q4 2022 | 4 | $264.4K |
| Q3 2022 | 2 | $17.0K |
| Q2 2022 | 3 | $27.0K |
| Q1 2022 | 3 | $332.0K |
| Q4 2021 | 2 | $517.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Genenta Science S.p.A.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allianz SE | 234,050 | $744.3K | 0.02% | 00.0% | Unchanged |
| AlTi Global, Inc. | 200,288 | $636.9K | 0.01% | 00.0% | Unchanged |
| Algebris (UK) Ltd | 100,000 | $327.7K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,486 | $41.0K | 0.00% | +12,486 | New |
| National Bank of Canada | 3,000 | $9.54K | 0.00% | +3,000 | New |
| Morgan Stanley | 2,200 | $7.00K | 0.00% | +200+10.0% | Added |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −982−100.0% | Sold out |